Schadendorf D - Search Results

1

Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.

Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, Gusenleitner D, Amaral T, Wyss N, Utikal J, Flatz L, Rambow F, Reinhardt HC, Dick J, Engel DR, Horn S, Ugurel S, Sondermann W, Livingstone E, Sucker A, Paschen A, Zhao F, Placke JM, Klose JM, Fendler WP, Thommen DS, Helfrich I, Schadendorf D, Roesch A. Váraljai R, et al. Among authors: schadendorf d. Nat Cancer. 2023 Sep;4(9):1292-1308. doi: 10.1038/s43018-023-00610-2. Epub 2023 Jul 31. Nat Cancer. 2023. PMID: 37525015 Free PMC article.

2

Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.

Zhao F, Falk C, Osen W, Kato M, Schadendorf D, Umansky V. Zhao F, et al. Among authors: schadendorf d. Clin Cancer Res. 2009 Jul 1;15(13):4382-90. doi: 10.1158/1078-0432.CCR-09-0399. Epub 2009 Jun 23. Clin Cancer Res. 2009. PMID: 19549770

3

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S. Paschen A, et al. Among authors: schadendorf d. Clin Cancer Res. 2009 Aug 15;15(16):5208-15. doi: 10.1158/1078-0432.CCR-09-0886. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671853

4

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.

Gast A, Scherer D, Chen B, Bloethner S, Melchert S, Sucker A, Hemminki K, Schadendorf D, Kumar R. Gast A, et al. Among authors: schadendorf d. Genes Chromosomes Cancer. 2010 Aug;49(8):733-45. doi: 10.1002/gcc.20785. Genes Chromosomes Cancer. 2010. PMID: 20544847

5

PLX4032: does it keep its promise for metastatic melanoma treatment?

Livingstone E, Zimmer L, Piel S, Schadendorf D. Livingstone E, et al. Among authors: schadendorf d. Expert Opin Investig Drugs. 2010 Nov;19(11):1439-49. doi: 10.1517/13543784.2010.527945. Epub 2010 Oct 14. Expert Opin Investig Drugs. 2010. PMID: 20942773 Review.

6

Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management.

Kaehler KC, Piel S, Livingstone E, Schilling B, Hauschild A, Schadendorf D. Kaehler KC, et al. Among authors: schadendorf d. Semin Oncol. 2010 Oct;37(5):485-98. doi: 10.1053/j.seminoncol.2010.09.003. Semin Oncol. 2010. PMID: 21074064 Review.

7

Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries.

Osen W, Soltek S, Song M, Leuchs B, Steitz J, Tüting T, Eichmüller SB, Nguyen XD, Schadendorf D, Paschen A. Osen W, et al. Among authors: schadendorf d. PLoS One. 2010 Nov 30;5(11):e14137. doi: 10.1371/journal.pone.0014137. PLoS One. 2010. PMID: 21152437 Free PMC article.

8

A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up.

Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, Rotterdam S, Ugurel S, Schadendorf D. Livingstone E, et al. Among authors: schadendorf d. Eur J Cancer. 2011 Sep;47(13):1977-89. doi: 10.1016/j.ejca.2011.04.029. Epub 2011 May 24. Eur J Cancer. 2011. PMID: 21612915

9

Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival.

Gast A, Bermejo JL, Claus R, Brandt A, Weires M, Weber A, Plass C, Sucker A, Hemminki K, Schadendorf D, Kumar R. Gast A, et al. Among authors: schadendorf d. PLoS One. 2011;6(9):e24370. doi: 10.1371/journal.pone.0024370. Epub 2011 Sep 9. PLoS One. 2011. PMID: 21931695 Free PMC article.

10

Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.

Heinemann A, Zhao F, Pechlivanis S, Eberle J, Steinle A, Diederichs S, Schadendorf D, Paschen A. Heinemann A, et al. Among authors: schadendorf d. Cancer Res. 2012 Jan 15;72(2):460-71. doi: 10.1158/0008-5472.CAN-11-1977. Epub 2011 Nov 18. Cancer Res. 2012. PMID: 22102694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,077 results

Search Page